Merck KGaA (MKKGY)
32.45
-0.28
(-0.86%)
USD |
OTCM |
Aug 28, 16:00
Merck Cash from Operations (Quarterly) : 706.85M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 706.85M |
| March 31, 2026 | 957.00M |
| December 31, 2025 | 1.479B |
| September 30, 2025 | 1.756B |
| June 30, 2025 | 634.85M |
| March 31, 2025 | 585.17M |
| December 31, 2024 | 1.352B |
| September 30, 2024 | 1.587B |
| June 30, 2024 | 924.68M |
| March 31, 2024 | 1.123B |
| December 31, 2023 | 1.093B |
| September 30, 2023 | 1.373B |
| June 30, 2023 | 683.17M |
| March 31, 2023 | 915.22M |
| December 31, 2022 | 983.64M |
| September 30, 2022 | 1.600B |
| June 30, 2022 | 910.94M |
| March 31, 2022 | 942.34M |
| December 31, 2021 | 1.187B |
| September 30, 2021 | 1.742B |
| June 30, 2021 | 1.069B |
| March 31, 2021 | 1.465B |
| December 31, 2020 | 1.535B |
| September 30, 2020 | 1.329B |
| June 30, 2020 | 549.19M |
| Date | Value |
|---|---|
| March 31, 2020 | 568.46M |
| December 31, 2019 | 727.20M |
| September 30, 2019 | 1.055B |
| June 30, 2019 | 835.16M |
| March 31, 2019 | 559.78M |
| December 31, 2018 | 865.38M |
| September 30, 2018 | 851.08M |
| June 30, 2018 | 442.88M |
| March 31, 2018 | 467.02M |
| December 31, 2017 | 758.89M |
| September 30, 2017 | 893.87M |
| June 30, 2017 | 564.06M |
| March 31, 2017 | 833.20M |
| December 31, 2016 | 867.86M |
| September 30, 2016 | 1.191B |
| June 30, 2016 | 350.84M |
| March 31, 2016 | 388.16M |
| December 31, 2015 | 812.94M |
| September 30, 2015 | 965.93M |
| June 30, 2015 | 362.37M |
| March 31, 2015 | 308.70M |
| December 31, 2014 | 1.469B |
| September 30, 2014 | 993.13M |
| June 30, 2014 | 589.70M |
| March 31, 2014 | 559.64M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| STRATEC SE | 9.404M |
| Sartorius AG | 182.17M |
| Petros Pharmaceuticals, Inc. | -0.8639M |
| Danaher Corp. | 1.534B |
| Illumina, Inc. | 201.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -710.40M |
| Cash from Financing (Quarterly) | -920.17M |
| Free Cash Flow | 38.93M |
| Free Cash Flow Per Share (Quarterly) | -0.2575 |
| Free Cash Flow to Equity (Quarterly) | -754.56M |
| Free Cash Flow to Firm (Quarterly) | -436.92M |
| Free Cash Flow Yield | 0.06% |